SIRIANNI, RACHAEL,MEDINA, DAVID ALEXANDRO,CHUNG, EUGENE
申请号：
CA3065793
公开号：
CA3065793A1
申请日:
2018.06.15
申请国别(地区):
CA
年份:
2018
代理人:
摘要：
The invention relates to a composition and use of the composition in the treatment of a disorder, for example, a neurological disease associated with retinoid signaling. The invention also includes the use of a retinoid encapsulated in nanoparticles. The retinoid encapsulated nanoparticles are adapted to increasing lifespan and conferring neuroprotective effects such as preserving motor units, reducing motor impairment, or reducing neuroinflammation in a subject.
